HighTower Advisors
OSTX

HighTower Advisors’s OS Therapies Inc OSTX Stock Holding History

HighTower Advisors’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.4K Buy
+15,200
New +$21.6K ﹤0.01% 3755

Other funds holding OSTX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighTower Advisors's OSTX Position: Q1 2026 in Review

HighTower Advisors opened a new position in OS Therapies Inc (OSTX) in Q1 2026: 15,200 shares worth $21.4K. The stake represents ﹤0.01% of the portfolio and ranks #3755 among its holdings.

29 funds tracked by Wall St. Rank hold OSTX as of Q1 2026.

  • HighTower Advisors held 15,200 shares of OS Therapies Inc worth $21.4K as of Q1 2026.
  • OS Therapies Inc was a new HighTower Advisors position in Q1 2026.
  • OS Therapies Inc made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3755 holding.
  • 29 funds tracked by Wall St. Rank held OS Therapies Inc as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.